AA Inventor Patents Life Saving Fluid for Severe Blood Loss and Septic Shock

Vivacelle Bio, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted it an Investigational New Drug (IND) clearance to proceed with its phase lla clinical trial of the safety and efficacy of VBI-1.